$43.36 Bn Autism Spectrum Disorder Diagnostics Global Market Trends, Opportunities And Strategies, 2019-2024, 2025-2029F, 2034F

(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities in the autism spectrum disorder diagnostics sector include growth in the autistic disorder segment, online pharmacies, and early intervention services. The Asian and European markets are poised for significant expansion. Companies should focus on AI innovations, strategic partnerships, and expanding diagnostics capabilities.

Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Autism Spectrum Disorder Diagnostics Global Market Opportunities And Strategies To 2034" has been added to ResearchAndMarkets's offering.

The global autism spectrum disorder (ASD) diagnostics market is on a trajectory to reach $43.36 billion by 2034, growing from $27.38 billion in 2024 at a compound annual growth rate (CAGR) of 5.06% until 2029. The market is primarily driven by increasing healthcare expenditure, rising investments in research and development, and government initiatives. Despite challenges such as limited healthcare infrastructure and the inherent complexity of ASD, opportunities abound.

Segment-wise, the autistic disorder segment is set to dominate, accounting for 52.82% of the total market in 2024, with an expected growth rate of 5.46% from 2024 to 2029. In terms of distribution channels, drug stores and retail pharmacies lead, while online pharmacies emerge as the fastest-growing segment with a staggering CAGR of 13.00% during the same period.

Service-wise, behavioral approaches captured 46.21% of the market share in 2024. However, early intervention services are expected to grow rapidly at a 6.14% CAGR through 2029, driven by a demand for personalized treatment approaches. Companies like Laboratory Corporation of America Holdings, Illumina Inc., and Bio-Rad Laboratories Inc. are major market players, collectively holding a minor percentage of the total market.

Regionally, North America holds the largest share, at 42.06% or $11.51 billion in 2024, followed closely by Asia Pacific. By 2029, Asia Pacific and Western Europe are expected to lead the growth among regions, with CAGRs of 6.01% and 5.16% respectively.

Strategic market-based opportunities point to the need for more innovative diagnostic aids and tools to improve early detection and diagnosis, alongside strategic partnerships and AI solutions in autism care. Emphasis on early intervention, emerging markets, and online pharmacies offers substantial growth potential. Market players are advised to engage in strategic collaborations, focus on competitive pricing, and leverage digital platforms to enhance accessibility and broaden reach.

Looking ahead, companies are recommended to invest in AI-driven diagnostic tools to improve accuracy and to capitalize on the fastest-growing segments like autistic disorder and early intervention. These strategies will not only streamline clinical trials but also maximize revenue by expanding access through digital channels and tiered pricing models.

The report covering the historic period of 2019-2024 and extending forecasts to 2029 and beyond, outlines these trends and projections in the global autism spectrum disorder diagnostics market.

Key Attributes:

Report Attribute	Details
No. of Pages	347
Forecast Period	2024 - 2034
Estimated Market Value (USD) in 2024	$27.38 Billion
Forecasted Market Value (USD) by 2034	$43.36 Billion
Compound Annual Growth Rate	4.7%
Regions Covered	Global

Companies Featured

• Laboratory Corporation of America Holdings (LabCorp)
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• Quest Diagnostics Incorporated
• Ambry Genetics Corp.
• ARUP Laboratories Inc
• Cortica Inc.
• GeneDx Holding Corp.
• Centogene N.V.
• Caravel Autism Health LLC
• Genetic Technologies Ltd (GTG)
• BGI Genomics
• Berry Genomics
• Annoroad Gene Technology
• KingMed Diagnostics
• MedGenome
• Green Cross LabCell
• Macrogen
• SYNLAB Group
• Qiagen
• Paloma Health
• Roche
• Merck Sharp & Dohme (MSD) Ireland
• EKF Diagnostics
• H. Lundbeck A/S
• Synevo
• Genetica
• Linus Biotechnology, Inc
• Thermo Fisher Scientific
• C.A.B.S. Autism and Behavior Specialists
• Schweitzer Engineering Laboratories
• Cognoa, Inc
• Marcus Autism Center
• EarliTec Diagnostics
• Autism Ontario
• Auticon
• Kinark
• Autism Speaks
• Diagnosticos da America S.A.
• Tismoo
• CellSave
• Seegene
• ALJ Health
• Sudair Pharma
• Gene Vector Technologies
• Aposense
• Augmental Technologies
• The Star Academy

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Global Autism Spectrum Disorder Diagnostics Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN08012026004107003653ID1110572020